Latest news & insights
Professor Alan Boyd awarded the Fellowship of the Academy of Medical Sciences
Boyds’ Founder and President, Professor Alan Boyd, has been awarded the Fellowship of the Academy of Medical Sciences. This prestigious award recognises Professor Boyd’s contributions
Boyds supports COVID-19 human infection study
Boyds is working in collaboration with Wellcome on a COVID-19 human infection study which aims to investigate the immunity provided by previous COVID-19 infections to
Opportunities in Clinical Research
One Nucleus recently hosted their Building Life Science Adventures Conference which focused on industry career opportunities, such as clinical research. The two-day event was held
Boyds appoints Neil Chakrabarti as Chief Financial Officer
Boyds is delighted to announce the appointment of Neil Chakrabarti as Chief Financial Officer. The appointment comes as the company reports a record-breaking 25 percent
Supporting the development and regulatory activities for the AstraZeneca-Oxford COVID-19 vaccine
The approval in December for the emergency use of the AstraZeneca-Oxford COVID-19 vaccine by the MHRA provided another key milestone in the response to the
Alan Boyd joins Taysha Gene Therapies’ independent scientific advisory board
Professor Alan Boyd has joined Taysha Gene Therapies’ newly formed independent scientific advisory board. Taysha Gene Therapies, Inc., a patient-centric gene therapy company focused on
Medical monitor support and advice for FLU-v phase IIb study for influenza
Each year, influenza affects up to 5 million people worldwide and leads to an estimated 650,000 deaths. Currently, the most effective available treatment is an
Dr Bryan Murray joins Clinical and Medical Affairs Team
Dr Bryan Murray has joined Boyds as a Pharmaceutical Physician within the growing Clinical and Medical Affairs team. Bryan Murray is an experienced trials physician
